Clinical Trial

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.
Protocol Amendment History 28 amendments
This ClinicalTrials.gov record has been amended 28 times since 2014-06-12; most recent amendment 2026-07-15.
Status change: Recruiting → Active, Not Recruiting 2018-01-29
Status change: Not Yet Recruiting → Recruiting 2015-12-14
Trial Details
NCT Number NCT02162849
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: NAL PHARMA, Pfizer
Conditions Tobacco Use Cessation
Enrollment 204 participants
Start Date 2015-12-14
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-16